Sequence analysis of Australian infectious bursal disease viruses.

Classification of infectious bursal disease virus into genogroups. Arch Virol (2017) 0.75

Localization and functional analysis of transposon mutations in regulatory genes of the TOL catabolic pathway. J Bacteriol (1983) 2.84

Transposon mutagenesis analysis of meta-cleavage pathway operon genes of the TOL plasmid of Pseudomonas putida mt-2. J Bacteriol (1984) 2.77

Transcription of the TOL plasmid toluate catabolic pathway operon of Pseudomonas putida is determined by a pair of co-ordinately and positively regulated overlapping promoters. EMBO J (1984) 2.74

Gene order of the TOL catabolic plasmid upper pathway operon and oxidation of both toluene and benzyl alcohol by the xylA product. J Bacteriol (1986) 2.66

Enzyme recruitment in vitro: use of cloned genes to extend the range of haloaromatics degraded by Pseudomonas sp. strain B13. J Bacteriol (1984) 2.10

Vector for regulated expression of cloned genes in a wide range of gram-negative bacteria. J Bacteriol (1986) 1.76

Functional analysis of the O antigen glucosylation gene cluster of Shigella flexneri bacteriophage SfX. Microbiology (1999) 1.48

Molecular relationships between pseudomonas INC P-9 degradative plasmids TOL, NAH, and SAL. Plasmid (1983) 1.47

Characterization by molecular cloning of insertion mutants in TOL catabolic functions. Plasmid (1983) 1.33

Molecular characterization of the genes involved in O-antigen modification, attachment, integration and excision in Shigella flexneri bacteriophage SfV. Gene (1997) 1.30

Roles of the divergent branches of the meta-cleavage pathway in the degradation of benzoate and substituted benzoates. J Bacteriol (1987) 1.29

Physical mapping of TOL plasmids pWWO and pND2 and various R plasmid-TOL derivatives from Pseudomonas spp. J Bacteriol (1982) 1.23

Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor. Proc Natl Acad Sci U S A (1988) 1.17

Genetic analysis and manipulation of catabolic pathways in Pseudomonas. Biochem Soc Symp (1983) 1.14

Use of cloned genes of Pseudomonas TOL plasmid to effect biotransformation of benzoates to cis-dihydrodiols and catechols by Escherichia coli cells. Appl Environ Microbiol (1985) 1.14

The identification and cloning of genes encoding haloaromatic catabolic enzymes and the construction of hybrid pathways for substrate mineralization. Basic Life Sci (1984) 0.99

Shigella flexneri type-specific antigen V: cloning, sequencing and characterization of the glucosyl transferase gene of temperate bacteriophage SfV. Gene (1997) 0.97

Identification of canine coronavirus strains from feces by S gene nested PCR and molecular characterization of a new Australian isolate. J Clin Microbiol (2001) 0.95

Mutants of Pseudomonas aeruginosa deficient in DNA polymerase I. Mutat Res (1976) 0.92

Characterization of the gene encoding a 26-kilodalton protein (OMP26) from nontypeable Haemophilus influenzae and immune responses to the recombinant protein. Infect Immun (1999) 0.92

The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK). Vet Microbiol (1995) 0.89

A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitis. Vet Microbiol (1993) 0.85

Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung. Vaccine (2000) 0.84

Molecular subtyping of feline immunodeficiency virus from domestic cats in Australia. Aust Vet J (2006) 0.84

A mutant of Pseudomonas aeruginosa deficient in an ATP-dependent deoxyribonuclease. J Gen Microbiol (1980) 0.84

The working mechanism of an immune complex vaccine that protects chickens against infectious bursal disease. Immunology (1998) 0.84

Nucleotide sequence of the F41 fimbriae subunit gene in Escherichia coli B41. Nucleic Acids Res (1989) 0.84

Protective antibody titres and antigenic competition in multivalent Dichelobacter nodosus fimbrial vaccines using characterised rDNA antigens. Vet Immunol Immunopathol (1994) 0.84

The effects of antigenic competition on the efficacy of multivalent footrot vaccines. Aust Vet J (1993) 0.82

Effect of repair deficiency and R plasmids on spontaneous and radiation-induced mutability in Pseudomonas aeruginosa. J Bacteriol (1979) 0.82

A haemolytic cell-free preparation of Moraxella bovis confers protection against infectious bovine keratoconjunctivitis. FEMS Microbiol Lett (1994) 0.82

Canine coronavirus in Australian dogs. Aust Vet J (2001) 0.81

R plasmids which alter ultraviolet light-sensitivity and enhance ultraviolet light-induced mutability in Pseudomonas aeruginosa. J Gen Microbiol (1978) 0.79

Recombinant fowlpox virus vaccines against Australian virulent Marek's disease virus: gene sequence analysis and comparison of vaccine efficacy in specific pathogen free and production chickens. Virus Res (1997) 0.77

The effect of time between doses on serological response to a recombinant multivalent pilus vaccine against footrot in sheep. Aust Vet J (1993) 0.76

Molecular comparisons of plasmids isolated from colicinogenic strains of Escherichia coli. J Gen Microbiol (1984) 0.75

Effect of bacteriophage C5 on ultraviolet light survival in Pseudomonas aeruginosa. J Gen Microbiol (1979) 0.75